Investigation of the Safety, Dosing Frequency and Anti-Scarring Potential of Two Concentrations of Intradermal Avotermin (Juvista)

NCT00978367 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

43

Enrollment

INDUSTRY

Sponsor class

Conditions

Cicatrix
Wound Healing
Re-epithelialization

Interventions

DRUG: Avotermin
DRUG: Avotermin
DRUG: Avotermin
DRUG: Placebo
DRUG: Placebo
DRUG: Placebo

Sponsor

Renovo